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We report an unexpected sudden cardiac death due to variant angina complicated by
ventricular ﬁbrillation occurring during routine ambulatory electrocardiographic monitoring.
The patient had one previous episode of ventricular ﬁbrillation before the lethal event. He had
no signiﬁcant coronary artery disease and was asymptomatic throughout his illness. In clinical
practice, when an episode of ventricular ﬁbrillation is noted, one should be aware of the risk
of sudden cardiac death, even if the patient’s vasospastic angina is relatively stable and
asymptomatic.
(J Arrhythmia 2005; 21: 546–552)
Key words:
Sudden death, Silent myocardial ischemia, Ambulatory electrocardiographic monitoring,
Implantable cardioverter-deﬁbrillators
Introduction
Patients with vasospastic angina (variant angina)
typically have angina symptoms at rest and show
ST-segment elevation on the electrocardiogram
(ECG). The symptoms and ST-segment elevation
are caused by coronary artery spasm. Generally,
isolated coronary spasm not related to coronary
artery obstruction has a favorable prognosis.1–3)
However, ventricular arrhythmia is frequently rec-
ognized as a complication of variant angina.4)
Variant angina without ﬁxed coronary obstruction
may rarely trigger lethal ventricular arrhythmia.1,2)
For patients with variant angina, medical treatment
with calcium channel antagonists with and without
nitrates appears to oﬀer a good prognosis. The
prognosis for patients with vasospastic angina
complicated by lethal ventricular arrhythmias and/
or having refractory anginal symptoms is also
reported to be relatively good. However, a recent
report shows that ventricular ﬁbrillation complicat-
ing vasospastic angina identiﬁes a patient population
at risk for sudden cardiac death, and that these
patients should be considered for implantable car-
dioverter-deﬁbrillators (ICD).5,6) Thus, the necessity
for more aggressive anti-arrhythmic treatments such
as an ICD implant is currently the subject of much
debate. We report a patient who had a poor prognosis
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with symptom-free variant angina pectoris compli-
cated by ventricular ﬁbrillation. A more aggressive
treatment strategy including ICD implantation might
have been eﬀective in this case.
Case Report
A 60-year-old man presented with symptoms of
lower abdominal discomfort of about two weeks
duration. He visited the outpatient clinic of the
gastroenterology section of the National Defense
Medical College Hospital Internal Medicine depart-
ment in April 2003. He denied any sleep disorders.
His past history was unremarkable except for a light
heat stroke three years earlier. His family history
revealed that his mother had angina pectoris. With
respect to coronary risk factors, he had smoked one
pack daily for 35 years, and there was a family
history of coronary artery disease. The physical
examination of the patient in the outpatient clinic
was unremarkable (height 167 cm, body weight 65
kg, blood pressure 137/72mmHg, pulse rate 82
beats/min and regular). The laboratory ﬁndings were
also normal. His chest X-ray (cardiothoracic ratio =
48%) and electrocardiogram (ECG) were normal
(Figure 1). Thus, ECG showed no ﬁndings suggesting
idiopathic ventricular ﬁbrillation, Brugada, long QT
and/or short QT syndromes.
Upper gastrointestinal tract and colonic endos-
copies revealed cancer of the stomach and of the
transverse colon. Abdominal computed tomography
showed no signs of abdominal invasion and no liver
or lymph node metastases. He was referred to the
First Department of Surgery in our hospital for
radical resection of the stomach and colon. General
anesthesia with nitrous oxide, oxygen, and sevoﬂur-
ane, combined with epidural anesthesia was planned
for his ﬁrst operation in June 2003, but ventricular
ﬁbrillation developed during the induction of anes-
thesia. Induction of anesthesia consisted of 5mg
vecuronium bromide and 70mg propofol given
intravenously. Immediately after intra-tracheal intu-
bation following induction of anesthesia, incessant
ventricular tachycardia developed and was followed
by ventricular ﬁbrillation. DC deﬁbrillation was
necessary to restore sinus rhythm. The ﬁrst operation
was abandoned due to inability to ﬁnd the cause of
ventricular ﬁbrillation. The monitoring ECG (modi-
ﬁed bipolar CM5 lead) showed no signiﬁcant
ischemic changes and the anesthesiologist noted no
problems related to the induction of anesthesia and
intubation.
The cardiology section was asked to consult on
the case and perform further evaluation. Two-
dimensional echocardiography showed normal ﬁnd-
ings, and an exercise treadmill stress test was
negative for ischemia with 6 METs. Ambulatory
ECG monitoring (NASA lead) revealed marked ST-
segment elevation (Figure 2) at night accompanied
by atypical angina symptoms, such as lightheaded-
ness. The CM5 lead, which was identical to the ECG
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Figure 1 Standard 12-leads ECG ﬁndings.
No signs of idiopathic ventricular ﬁbrillation, Brugada, long QT and/or short QT syndrome were observed.
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lead monitored during the ﬁrst operation, showed no
signiﬁcant ST-segment changes. The coronary an-
giogram showed normal coronary arteries. Since
ambulatory ECG ﬁndings combined with a normal
coronary angiogram are compatible with coronary
vasospasm, no pharmacological provocation test for
vasospasm was performed.
During the second operation in July 2003, intra-
venous nitroglycerin, diltiazem, and nicorandil were
given during anesthesia, and a radical resection of
the cancerous stomach and colon was successfully
and uneventfully performed without any serious
arrhythmia. The patient was discharged having had
an uneventful postoperative clinical course.
The patient was followed by the cardiology
outpatient clinic, and was treated with nifedipine
CR 40mg daily and isosorbide dinitrate 20mg b.i.d.
Since the patient was asymptomatic, ambulatory
ECG was repeated every six months to monitor for
silent vasospastic anginal episodes and arrhythmias.
The second and third ambulatory ECGs were
unremarkable. Thus, no signiﬁcant ST-segment
changes and no arrhythmias were observed in these
ambulatory ECGs. It had been conﬁrmed that the
patient was compliant regarding his medications so
that he was considered to be properly treated during
the follow-up periods. In October 2004, a routine
ambulatory ECG was started. The next day, while
ambulatory ECG monitoring was still ongoing, the
patient was brought to our emergency room with a
cardiopulmonary arrest. The ambulatory ECG re-
vealed incessant marked ST-segment elevation with
a spontaneous resolution that started around 01:00
AM (Figure 3-1). Around 04:00AM, these ST-seg-
ment elevation episodes began to be complicated by
incessant ventricular tachycardia and, ﬁnally, the
development of ventricular ﬁbrillation and cardiac
arrest (Figure 3-2 and Figure 3-3). According to the
patient’s spouse, the patient slept through these
episodes, and when he was found unconscious in the
morning he was brought to our emergency room by
ambulance. He could not be resuscitated, and a
request for autopsy was not granted. Before lethal
ST-segment elevation started, any arrhythmias in-
cluding premature ventricular contractions were
recorded. In addition, his family reported that he
had good compliance for medication and that he had
no signs of acute illness suggesting myocarditis or
gastroenteritis and no evidence of alcohol abuse or
drug addiction.
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Figure 2 Ambulatory ECG monitoring ﬁndings.
ST-segment trend gram and real time electrocardiogram strip show marked ST-segment elevation compatible with vasospasm. The patient
complained of dull-headedness, which is an atypical symptom of angina. Premature ventricular contractions were observed on this strip.
Monitoring ECG was NASA lead. Please note, ST-segment was observed on NASA lead whereas no signiﬁcant ST-segment changes were
revealed on CM5 lead. Channel-1 (Ch-1) was NASA while channel-2 (Ch-2) was CM5 lead.
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Discussion
Our case demonstrates that unexpected cardiac
sudden death can occur in symptom-free variant
angina patients even though they appear to be
successfully treated with calcium channel antago-
nists and nitrates. A more aggressive treatment
strategy, such as ICD implantation, could have been
eﬀective in this case. In our patient, ambulatory
ECG was done every six months in order to
determine if the patient had developed silent my-
ocardial ischemia. Two ambulatory ECG recordings
revealed no signiﬁcant ﬁndings of silent myocardial
ischemia. The last ambulatory ECG recording was
performed as a scheduled examination. It document-
ed repeat silent myocardial ischemia and incessant
ventricular tachycardia that developed gradually and
ﬁnally led to lethal ventricular ﬁbrillation. During
these episodes, the patient was sleeping, and his
spouse did not recognize any abnormalities. Thus,
the patient’s ﬁnal episodes were considered as being
totally silent. Until the unexpected sudden death, the
cardiologist in charge had considered that the
patient’s angina was stable and well controlled by
medical treatment. In addition, two-dimensional
echocardiography, exercise treadmill testing as well
as ambulatory ECG monitoring were within normal
limits, except the variant angina type of ST-segment
elevation accompanying premature ventricular con-
tractions in this case. No ECG signs of idiopathic
ventricular ﬁbrillation, or Brugada or long QT
syndrome were observed so that ventricular ﬁbrilla-
tion induced during operation is considered as
ischemia-induced ventricular ﬁbrillation.
The prognosis in patients with isolated coronary
spasm is generally reported to be good. However, a
few patients show a poor prognosis. Nevertheless,
the overall long-term outcome for all vasospastic
angina patients is favorable. With approximately 5–
10 years of follow-up, the reported cardiac event
rates are about 2%–4% for cardiac death and about
5%–6% for nonfatal myocardial infarction.2,3) The
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Figure 3-1
Figure 3-1 to 3-3 Ambulatory ECG monitoring ﬁndings during the lethal episode.
When the patient was asleep, episodes of marked ST-segment elevation were recognized in both ST-
segment trend gram and real time electrocardiogram strips. At ﬁrst, ST-segment elevation was
spontaneously relieved. However, ventricular arrhythmias gradually complicated the situation, and ﬁnally
ventricular ﬁbrillation occurred.
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clinical characteristics that correlate with an unto-
ward outcome in vasospastic angina pectoris patients
are: organic coronary disease (obstruction);7–9) fre-
quent or refractory anginal symptoms;6) multi-vessel
spasm;10) and serious arrhythmia, such as ventricular
ﬁbrillation, complicating vasospastic angina pecto-
ris.11,12) Our patient had ventricular ﬁbrillation and
may have possibly had multivessel spasm, though
the latter was not conﬁrmed.
One important point that should be made with
respect to this case is that the index episode of
ventricular ﬁbrillation was not totally spontaneous
but rather was provoked by anesthesia. Strictly
speaking, this patient did not experience any truly
spontaneous lethal arrhythmias. Under such circum-
stances, our patient would have been classiﬁed in a
relatively low risk category for sudden cardiac death
according to previous reports.2,3) Despite this, sud-
den cardiac death occurred unexpectedly.
The novel ﬁnding of this case is that, even if silent
myocardial ischemia is successfully treated, unex-
pected sudden cardiac death can still take place in
well-controlled vasospastic angina pectoris patients.
Since the physician in charge recognized that vaso-
spastic angina has been well controlled by medica-
tion, the increase in dose of medicine could not be
conducted as the treatment option in this case.
However, it is possible that these patients could be
rescued by more aggressive treatment such as ICD. It
has been reported that with the onset of silent
myocardial ischemia, a lethal arrhythmic event can
occur in asymptomatic vasospastic angina pectoris
patients.13) Recent studies have shown that vaso-
spastic angina pectoris patients whose course is
complicated by lethal arrhythmia are prone to
sudden cardiac death.13,14) The lethal arrhythmia
need not be spontaneous, but electrophysiological
study-induced ventricular tachycardia or ventricular
ﬁbrillation could also be a risk factor for sudden
cardiac death.14) Since most of the ischemic episodes
in vasospastic angina pectoris patients have been
reported to be silent,15) more aggressive assessment
and/or treatment is necessary in vasospastic angina
pectoris patients who have suspected lethal arrhyth-
mias.
Reviewing this case, several criticisms may be
raised. First, the patient was not assessed for
multivessel spasm. The presence of multivessel
spasm is one of the risk factors for sudden cardiac
death. A provocation test should be performed in
suspected high-risk vasospastic angina pectoris
patients. Secondly, we did not conﬁrm the eﬃcacy
of the medical treatment by using a catheter-based
provocation test during medical therapy recommend-
ed by the previous reports.12,13) This procedure
would also have been beneﬁcial in avoiding un-
expected sudden cardiac death. Lastly, unfortunately
we did not assess the eﬃcacy of an ICD for this
patient.
Taking all this into account, a more aggressive
treatment strategy such as ICD implantation and/or
catheter-based provocation studies would likely have
been eﬀective in this case. Thus, careful evaluation
and an awareness of the possibility of sudden cardiac
death are important in clinical practice, even if the
vasospastic angina pectoris patient seems to be
stable.
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